Results

Total Results: 1,169 records

Showing results for "patient safety".

261. Anxiety in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/anxiety-children_research-protocol.pdf
     September 12, 2016 - There is a great deal of uncertainty regarding comparative effectiveness and safety of all treatments … that are widely available and validated; which are:(patients/parent reported and clinician assessed … What are the treatment burdens (for patients, providers, and health systems) and contextual factors … specific phobias, generalized • Animals • Adults (age >= 18 years) • Infants (age < 3 years) • Patients … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing

262. AHRQ’s Evidence-based Practice Center Program- Synthesizing evidence to improve health care practice and delivery (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-evidence-reviews-federal-agencies.pdf
     July 01, 2020 - Department of Health and Human Services that is charged with improving the quality, safety, efficiency … effectivehealthcare. ahrq.gov/topics/field-triage-glascow/ research-2017) National Highway Traffic Safety … ://www.pcori.org/sites/default/ files/PCORI-Addressing-Disparities- Topic-Brief-1-to-6-011314.pdf) Patient-Centered

263. Comparative Effectiveness of Pain Management Interventions fo Hip Fracture (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hip-fracture-pain.ppt
     May 01, 2011 - effectiveness and safety? … Evidence about the patient subpopulation characteristics that influence effectiveness and safety was … It is important to note that no studies examined the effectiveness or safety of the most commonly used … The evidence may support continued research to test effectiveness and safety. … Influence of Subpopulation Characteristics on Effectiveness and Safety (2) Abou-Setta AM, Beaupre LA,

264. Comparative Effectiveness of Pain Management Interventions fo Hip Fracture (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/hip-fracture-pain.ppt
     May 01, 2011 - effectiveness and safety? … Evidence about the patient subpopulation characteristics that influence effectiveness and safety was … It is important to note that no studies examined the effectiveness or safety of the most commonly used … The evidence may support continued research to test effectiveness and safety. … Influence of Subpopulation Characteristics on Effectiveness and Safety (2) Abou-Setta AM, Beaupre LA,

265. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - According to the Cystic Fibrosis Foundation’s 2014 patient registry, almost 47% of CF patients in the … One phase III trial is ongoing, evaluating pirfenidone’s long-term safety and efficacy in patients … However, experts thought that patients are likely to accept lumacaftor/ivacaftor if long-term safety … Safety and efficacy of treatment with lumacaftor in combination with ivacaftor in patients with CF … Safety and tolerability of nintedanib in patients with Ipf: interim analysis from an open-label extension

266. AHRQ’s Evidence-based Practice Center Program: Synthesizing evidence to improve health care practice and delivery (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-health-care-practice-delivery.pdf
     November 01, 2022 - models of care (e.g., impact of telehealth on health outcomes, mobile health technology for diabetes, patient … safety in ambulatory settings).

267. Gout Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
     March 01, 2016 - Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic … Diabetes and gout: efficacy and safety of febuxostat and allopurinol. … The efficacy and safety of febuxostat for urate lowering in gout patients >/=65 years of age. … African American patients with gout: efficacy and safety of febuxostat vs allopurinol. … Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout.

268. Ch 6-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
     October 30, 2012 - thrombosis (ST)], and two relating to both safety and effectiveness [composite of death, MI, ST, … The safety-only definition of MACE yielded a hazard ratio of 1.75 (p<0.05), indicating that patients … definitions also yielded different results; while the safety- only composite endpoint demonstrated … This construct comprises outcomes from the patient perspective and are measured by asking the patient … using clozapine may appear to have a worse safety profile with respect to this outcome.

269. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
     April 01, 2011 - Summary of available data on patient characteristics and response to prior medical treatment have been … The subjective parameters should also include Patient Reported Outcomes (PROs) as appropriate instruments … At baseline and Week 4 (Final Visit), 3 patient-reported outcome questionnaires were completed to assess … comprising 11% of patients in the trials.1 No overall differences were seen in the safety or effectiveness … The safety of Thank you for your comments.

270. AHRQ Evidence-based Practice Center Program Research Gaps Summary: Telehealth (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ehc-research-gaps-telehealth.pdf
     April 01, 2023 - • Some patients perceive telehealth as a barrier to improved health outcomes owing to the absence … • P-P telehealth to support direct patient care may provide benefits for in patient care, for neonates … Interventions • Studies to determine the optimal structure and safety for routine and alternative … , and are cost-effective for the health system, patients, and their caregivers. … depression, fear of partner, coercive control, self-efficacy, post-traumatic stress disorder, and safety

271. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
     January 01, 2014 - IL-1 may be a problematic target with respect to safety in the gout patient population, however, and … and tolerability due to safety concerns over infections reported in trials thus far. … These safety concerns may present barriers to approval or barriers to diffusion if approved. … These safety concerns may present significant barriers to approval and diffusion if approved. … SLE: belimumab safety, efficacy sustained over 6 years. [internet].

272. Ch 1-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
     August 13, 2012 - end-users and facilitates appropriate translation of the results into health care practice and use by patient … If the FDA approves, human testing for safety and efficacy can begin. … These endpoints may be categorized as clinical endpoints, patient-reported outcomes and quality of … On the other hand, a patient who has a health condition where there are few treatments may be willing … Likewise, some patient groups were reported to be concerned by the decision since it presumably would

273. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
     September 18, 2012 - System (VAERS),11 the Vaccine Safety Datalink,12 and the Clinical Immunization Safety Assessment Network … Both patient factors (i.e., age and race) and vaccine factors (i.e., formulation, dosage, and timing … AEs) or passive (participants are not specifically asked about or tested for the occurrence of AEs; patient … Multiple publications are defined by the investigated patients. F. … The Vaccine Safety Datalink: a model for monitoring immunization safety.

274. Asthma-Immunotherapy-2010 Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2010_research-protocol.pdf
     January 01, 2010 - With continued administration, it is expected that the treatment regimen will make the patient tolerant … KQ 2 What is the evidence for safety of SIT in patients with allergic rhinoconjunctivitis and/or … Safety of long-acting beta2-agonists in the treatment of asthma. … Not all patients with asthma are allergic. … The activity domain contains 5 ‘patient-specific’ questions.

275. Evidence Summary CER 208 Treatment For Bipolar Disorder In Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
     August 01, 2018 - Future research should also enroll people with different patient characteristics and initial episodes … Are bipolar II patients cognitively impaired? A systematic review. … Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in … A randomized, double- blind, placebo-controlled efficacy and safety study of quetiapine or lithium as … Treatment in a specialised out-patient mood disorder clinic v. standard out-patient treatment in the

276. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
     September 26, 2014 - Patients and their diabetes care teams work to adjust patient insulin dosages using feedback from a … health outcomes, citing safety concerns and limited efficacy data. … Summary of safety and effectiveness data (SSED). MiniMed 530G system. P120010. … Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients … A study of the safety and efficacy of a new treatment for diabetic macular edema.

277. Urinary-Incontinence-Treatment Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
     October 29, 2012 - • There are no safety concerns Summary Decision: This CER’s priority for updating is Low … UUI in 40% patients on 150 U; p=0.022 • >75% improvement versus baseline in UUI in 40% patients on 100 … UUI in 40% patients on 150 U; p=0.022 >75% improvement versus baseline in UUI in 40% patients on … The  efficacy  and  safety  of  solifenacin   in  patients  with  overactive  bladder … in 40% patients on 150 U; p=0.022 >75% improvement versus baseline in UUI in 40% patients on 100

278. ECRI_Penn EPC FINAL Environ Cleaning Protocol 08_21_14 CC[1] (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/healthcare-infections_research-protocol.pdf
     January 01, 2014 - What criteria (clinical effectiveness, safety, adherence to FDA regulations, market value, others) … of patients (family/guests)? … Centers for Disease Control and Prevention (CDC), Environmental Protection Agency (EPA), Occupational Safety … searched to identify clinical practice guidelines, white papers or position statements, regulatory or safety … OR "patient rooms" OR "patients rooms" OR "health care setting" OR "health care settings" OR ward OR

279. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Preliminary data for these interventions are promising, and ongoing trials are clarifying the safety … Results and Discussion of Comments Seven experts, with clinical, research, patient safety, and health … widespread, if data support its efficacy and safety, the experts thought. … Investigators reported high patient adherence (81% and 94%; adherence defined as patients completing … that SPARX could positively affect patient health outcomes by providing an alternative for patients

280. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
     January 01, 2012 - significantly increased the regulatory bar for gaining approval—specifically regarding preapproval safety … data and postmarket safety evaluation—set forth by the U.S. … Kushner and colleagues announced results from a phase III clinical trial (SEQUEL) evaluating the safety … However, potential increase in per- patient costs might serve as barriers to acceptance by some patients … Safety and efficacy study of EndoBarrier in subjects with type II diabetes and obesity.